Innovestor
VC Fund
Helsinki, Finland
Innovestor is a nordic venture capital investor and financial services company. For investors, Innovestor offers attractive opportunities to invest in carefully selected growth companies. For growth companies, Innovestor offers funding at competitive terms and valuable insight from a team of experienced professionals and industry experts.Innovestor offices are located in Helsinki, Jyväskylä, Stockholm and Moscow. Innovestor Ltd. is supervised by Finnish Financial Supervisory Authority.
- Total investments:
- 97
- Last investment:
- Lead investor:
- 56%
- Fund size:
- $33M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Innovestor invests in
Stages Innovestor invests in
Countries Innovestor invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $477k–$4.5M
- Pre-Seed
- $204k–$2M
- Venture - Series Unknown
- $529k–$5.1M
Investment Focus
Industry
- Software 15 (15%)
- Health Care 12 (12%)
- Information Technology 12 (12%)
- Medical 11 (11%)
- Manufacturing 9 (9%)
Stage
- Seed 28 (29%)
- Venture - Series Unknown 19 (20%)
- Pre-Seed 15 (15%)
- Series A 15 (15%)
- Funding Round 5 (5%)
Country
- Finland 59 (61%)
- Sweden 6 (6%)
- Denmark 4 (4%)
- United States 2 (2%)
- Norway 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hannu Jungman
Partner, Innovestor Ventures
|
Partner, Innovestor Ventures | Total investments: 4 | Find email | |
Janne Juhola
Partner
|
Partner | Total investments: 0 | Find email | |
Myron Seto
Partner
|
Partner | Total investments: 6 | Find email | |
Petri Laine
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
Wilhelm Lindholm
Partner and CEO
|
Partner and CEO | Total investments: 5 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure. | $70.8M / Series B / Sep 30, 2026 | ||
| Khoy Company designs and develops comfortable, user-friendly, and sustainable sofa beds. | $2.3M / Venture - Series Unknown / Sep 30, 2026 | ||
| Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases. | $76.7M / Series A / Sep 29, 2026 | ||
| Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered | $34.2M / Series A / Sep 24, 2026 | ||
| Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams. | Seed / Aug 13, 2026 | ||
| The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can. | $1.2M / Angel / Aug 12, 2026 | ||
| CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care. | $1.3M / Pre-Seed / Jul 13, 2026 | ||
| Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity. | $416.2K / Pre-Seed / May 19, 2026 | ||
| Reinventing the housing market with no agents, more homes, and less fees. | $584.7K / Seed / Apr 13, 2026 | ||
| Capalo AI offers a state-of-the-art Artificial Intelligence platform for the energy industry. | $13M / Series A / Feb 06, 2026 | ||
| See all 97 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Innovestor invest in?
Innovestor invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Venture - Series Unknown stage. Most of the 97 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Innovestor's check size?
Innovestor typically joins rounds of $477k–$4.5M at Seed, $204k–$2M at Pre-Seed and $529k–$5.1M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Innovestor participates in.
How do I contact Innovestor?
Public channels for Innovestor include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Innovestor?
The team at Innovestor includes Hannu Jungman (Partner, Innovestor Ventures), Janne Juhola (Partner) and Myron Seto (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
